I have read with interest numerous articles discussing the possible Brexit Bonuses available to the UK. Principle among these bonuses is refining Solvency II regulation to better reflect the UK’s leading global (re)insurance industry.
This GCP Short, produced in partnership with Marsh Health and Benefits, is all about the use of cells to structure captive employee benefits programmes.
